Suppr超能文献

有限蛋白酶解作为一种工具,用于探究dysferlin的三级构象以及患者错义变体L344P的结构后果。

Limited proteolysis as a tool to probe the tertiary conformation of dysferlin and structural consequences of patient missense variant L344P.

作者信息

Woolger Natalie, Bournazos Adam, Sophocleous Reece A, Evesson Frances J, Lek Angela, Driemer Birgit, Sutton R Bryan, Cooper Sandra T

机构信息

From the Institute for Neuroscience and Muscle Research, Kids Research Institute, The Children's Hospital at Westmead, Locked Bag 4001, Westmead 2145, Australia.

Discipline of Child and Adolescent Health, Faculty of Medicine, University of Sydney, Sydney 2006, Australia, and.

出版信息

J Biol Chem. 2017 Nov 10;292(45):18577-18591. doi: 10.1074/jbc.M117.790014. Epub 2017 Sep 13.

Abstract

Dysferlin is a large transmembrane protein that plays a key role in cell membrane repair and underlies a recessive form of inherited muscular dystrophy. Dysferlinopathy is characterized by absence or marked reduction of dysferlin protein with 43% of reported pathogenic variants being missense variants that span the length of the dysferlin protein. The unique structure of dysferlin, with seven tandem C2 domains separated by linkers, suggests dysferlin may dynamically associate with phospholipid membranes in response to Ca signaling. However, the overall conformation of the dysferlin protein is uncharacterized. To dissect the structural architecture of dysferlin, we have applied the method of limited proteolysis, which allows nonspecific digestion of unfolded peptides by trypsin. Using five antibodies spanning the dysferlin protein, we identified a highly reproducible jigsaw map of dysferlin fragments protected from digestion. Our data infer a modular architecture of four tertiary domains: 1) C2A, which is readily removed as a solo domain; 2) midregion C2B-C2C-Fer-DysF, commonly excised as an intact module, with subdigestion to different fragments suggesting several dynamic folding options; 3) C-terminal four-C2 domain module; and 4) calpain-cleaved mini-dysferlin, which is particularly resistant to proteolysis. Importantly, we reveal a patient missense variant, L344P, that largely escapes proteasomal surveillance and shows subtle but clear changes in tertiary conformation. Accompanying evidence from immunohistochemistry and flow cytometry using antibodies with conformationally sensitive epitopes supports proteolysis data. Collectively, we provide insight into the structural topology of dysferlin and show how a single missense mutation within dysferlin can exert local changes in tertiary conformation.

摘要

dysferlin是一种大型跨膜蛋白,在细胞膜修复中起关键作用,是隐性遗传性肌肉营养不良的基础。dysferlin病的特征是dysferlin蛋白缺失或显著减少,报告的致病变体中有43%是错义变体,分布在dysferlin蛋白的全长范围内。dysferlin具有独特的结构,由七个串联的C2结构域通过连接子隔开,这表明dysferlin可能响应钙信号而与磷脂膜动态结合。然而,dysferlin蛋白的整体构象尚未明确。为了解析dysferlin的结构架构,我们应用了有限蛋白酶解方法,该方法允许胰蛋白酶对未折叠的肽进行非特异性消化。使用跨越dysferlin蛋白的五种抗体,我们确定了一个高度可重复的dysferlin片段拼图图谱,这些片段受到保护不被消化。我们的数据推断出四个三级结构域的模块化架构:1)C2A,它很容易作为一个单独的结构域被去除;2)中间区域C2B-C2C-Fer-DysF,通常作为一个完整的模块被切除,亚消化成不同的片段表明有几种动态折叠选项;3)C端四个C2结构域模块;4)钙蛋白酶切割的微型dysferlin,它对蛋白酶解特别有抗性。重要的是,我们发现了一个患者错义变体L344P,它在很大程度上逃避了蛋白酶体的监测,并在三级构象中显示出细微但明显的变化。使用具有构象敏感表位的抗体进行免疫组织化学和流式细胞术的伴随证据支持了蛋白酶解数据。总体而言,我们深入了解了dysferlin的结构拓扑,并展示了dysferlin内的单个错义突变如何在三级构象中产生局部变化。

相似文献

1
2
Reduced plasma membrane expression of dysferlin mutants is attributed to accelerated endocytosis via a syntaxin-4-associated pathway.
J Biol Chem. 2010 Sep 10;285(37):28529-39. doi: 10.1074/jbc.M110.111120. Epub 2010 Jul 1.
3
The C2 domains of dysferlin: roles in membrane localization, Ca signalling and sarcolemmal repair.
J Physiol. 2022 Apr;600(8):1953-1968. doi: 10.1113/JP282648. Epub 2022 Mar 8.
4
Proteasomal inhibition restores biological function of mis-sense mutated dysferlin in patient-derived muscle cells.
J Biol Chem. 2012 Mar 23;287(13):10344-10354. doi: 10.1074/jbc.M111.329078. Epub 2012 Feb 8.
6
Calpain cleavage within dysferlin exon 40a releases a synaptotagmin-like module for membrane repair.
Mol Biol Cell. 2014 Oct 1;25(19):3037-48. doi: 10.1091/mbc.E14-04-0947. Epub 2014 Aug 20.
7
Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy.
Am J Pathol. 2009 Nov;175(5):1817-23. doi: 10.2353/ajpath.2009.090107. Epub 2009 Oct 15.
8
Proteasome inhibitors increase missense mutated dysferlin in patients with muscular dystrophy.
Sci Transl Med. 2014 Aug 20;6(250):250ra112. doi: 10.1126/scitranslmed.3009612.
9
Modular dispensability of dysferlin C2 domains reveals rational design for mini-dysferlin molecules.
J Biol Chem. 2012 Aug 10;287(33):27629-36. doi: 10.1074/jbc.M112.391722. Epub 2012 Jun 26.
10
Structure-Based Designed Nano-Dysferlin Significantly Improves Dysferlinopathy in BLA/J Mice.
Mol Ther. 2017 Sep 6;25(9):2150-2162. doi: 10.1016/j.ymthe.2017.05.013. Epub 2017 Jun 16.

引用本文的文献

1
Structural insights into lipid membrane binding by human ferlins.
EMBO J. 2025 May 28. doi: 10.1038/s44318-025-00463-8.
2
Cryo-EM structures of the membrane repair protein dysferlin.
Nat Commun. 2024 Nov 7;15(1):9650. doi: 10.1038/s41467-024-53773-6.
3
Role of calcium-sensor proteins in cell membrane repair.
Biosci Rep. 2023 Feb 27;43(2). doi: 10.1042/BSR20220765.
4
Owning, not doing: my transition from master's to PhD student.
Nature. 2022 Jan 18. doi: 10.1038/d41586-022-00135-1.
5
Proteasome inhibitors reduce thrombospondin-1 release in human dysferlin-deficient myotubes.
BMC Musculoskelet Disord. 2020 Nov 27;21(1):784. doi: 10.1186/s12891-020-03756-7.
6
Characterization of the High-Affinity Drug Ligand Binding Site of Mouse Recombinant TSPO.
Int J Mol Sci. 2019 Mar 21;20(6):1444. doi: 10.3390/ijms20061444.

本文引用的文献

1
Pathogenic mutation R959W alters recognition dynamics of dysferlin inner DysF domain.
Mol Biosyst. 2016 Mar;12(3):973-81. doi: 10.1039/c5mb00772k.
2
Broadening the imaging phenotype of dysferlinopathy at different disease stages.
Muscle Nerve. 2016 Aug;54(2):203-10. doi: 10.1002/mus.25045. Epub 2016 May 26.
4
Membrane Repair: Mechanisms and Pathophysiology.
Physiol Rev. 2015 Oct;95(4):1205-40. doi: 10.1152/physrev.00037.2014.
5
CD4+ cells, macrophages, MHC-I and C5b-9 involve the pathogenesis of dysferlinopathy.
Int J Clin Exp Pathol. 2015 Mar 1;8(3):3069-75. eCollection 2015.
6
Toward an objective measure of functional disability in dysferlinopathy.
Muscle Nerve. 2016 Jan;53(1):49-57. doi: 10.1002/mus.24685. Epub 2015 May 23.
7
Membrane Injury and Repair in the Muscular Dystrophies.
Neuroscientist. 2015 Dec;21(6):653-68. doi: 10.1177/1073858414558336. Epub 2014 Nov 18.
8
Calpain cleavage within dysferlin exon 40a releases a synaptotagmin-like module for membrane repair.
Mol Biol Cell. 2014 Oct 1;25(19):3037-48. doi: 10.1091/mbc.E14-04-0947. Epub 2014 Aug 20.
9
Quantitation of the calcium and membrane binding properties of the C2 domains of dysferlin.
Biophys J. 2014 Jan 21;106(2):382-9. doi: 10.1016/j.bpj.2013.11.4492.
10
Crystal structures of the human Dysferlin inner DysF domain.
BMC Struct Biol. 2014 Jan 17;14:3. doi: 10.1186/1472-6807-14-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验